These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 32249409

  • 1. Triage options to manage high-risk human papillomavirus-positive women: A population-based cross-sectional study from rural China.
    Rezhake R, Chen F, Hu SY, Zhao XL, Zhang X, Cao J, Qiao YL, Zhao FH, Arbyn M.
    Int J Cancer; 2020 Oct 15; 147(8):2053-2064. PubMed ID: 32249409
    [Abstract] [Full Text] [Related]

  • 2. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16INK4a immunostaining in China.
    Song F, Yan P, Huang X, Wang C, Qu X, Du H, Wu R.
    BMC Infect Dis; 2021 Apr 30; 21(1):400. PubMed ID: 33931022
    [Abstract] [Full Text] [Related]

  • 3. Clinical evaluation of p16INK4a immunocytology in cervical cancer screening: A population-based cross-sectional study from rural China.
    Rezhake R, Wang Y, Chen F, Hu SY, Zhang X, Cao J, Qiao YL, Zhao FH, Arbyn M.
    Cancer Cytopathol; 2021 Sep 30; 129(9):679-692. PubMed ID: 33826790
    [Abstract] [Full Text] [Related]

  • 4. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep 30; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 5. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
    Stanczuk GA, Baxter GJ, Currie H, Forson W, Lawrence JR, Cuschieri K, Wilson A, Patterson L, Govan L, Black J, Palmer T, Arbyn M.
    Cancer Epidemiol Biomarkers Prev; 2017 Nov 30; 26(11):1629-1635. PubMed ID: 28887297
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of p16INK4a immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
    Song F, Belinson JL, Yan P, Huang X, Wang C, Du H, Qu X, Wu R.
    Gynecol Oncol; 2021 Aug 30; 162(2):322-330. PubMed ID: 34059349
    [Abstract] [Full Text] [Related]

  • 7. p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
    Trzeszcz M, Mazurec M, Jach R, Mazurec K, Kotkowska-Szeps I, Kania M, Wantuchowicz M, Wasowska J, Duczek-Polakiewicz M, Rozmus P, Streb J, Halon A.
    J Med Virol; 2023 Nov 30; 95(11):e29271. PubMed ID: 38009626
    [Abstract] [Full Text] [Related]

  • 8. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C, Bakhiet S, Bates M, Keegan H, Pilkington L, Ruttle C, Sharp L, O' Toole S, Fitzpatrick M, Flannelly G, O' Leary JJ, Martin CM.
    Cytopathology; 2016 Aug 30; 27(4):269-76. PubMed ID: 26932360
    [Abstract] [Full Text] [Related]

  • 9. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
    Giorgi Rossi P, Carozzi F, Ronco G, Allia E, Bisanzi S, Gillio-Tos A, De Marco L, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Barca A, Bonvicini L, Mancuso P, Venturelli F, Benevolo M, the New Technology for Cervical Cancer 2 Working Group.
    J Natl Cancer Inst; 2021 Mar 01; 113(3):292-300. PubMed ID: 32745170
    [Abstract] [Full Text] [Related]

  • 10. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358
    [Abstract] [Full Text] [Related]

  • 11. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
    Torres-Ibarra L, Cuzick J, Lorincz AT, Spiegelman D, Lazcano-Ponce E, Franco EL, Moscicki AB, Mahmud SM, Wheeler CM, Rivera-Paredez B, Hernández-López R, León-Maldonado L, Salmerón J, FRIDA Study Group..
    JAMA Netw Open; 2019 Nov 01; 2(11):e1915781. PubMed ID: 31747033
    [Abstract] [Full Text] [Related]

  • 12. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X, Liao G, Sun L, Zhang Y, Chen W, Qiao YL.
    Cancer Prev Res (Phila); 2020 Feb 01; 13(2):163-172. PubMed ID: 31871224
    [Abstract] [Full Text] [Related]

  • 13. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
    Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G, New Technologies for Cervical Cancer Screening Working Group.
    Int J Cancer; 2020 Oct 01; 147(7):1864-1873. PubMed ID: 32170961
    [Abstract] [Full Text] [Related]

  • 14. Clinical Performance of Triage Strategies for Hr-HPV-Positive Women; A Longitudinal Evaluation of Cytology, p16/K-67 Dual Stain Cytology, and HPV16/18 Genotyping.
    Stanczuk G, Currie H, Forson W, Baxter G, Lawrence J, Wilson A, Palmer T, Arbyn M, Cuschieri K.
    Cancer Epidemiol Biomarkers Prev; 2022 Jul 01; 31(7):1492-1498. PubMed ID: 35511738
    [Abstract] [Full Text] [Related]

  • 15. Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.
    Benevolo M, Ronco G, Mancuso P, Carozzi F, De Marco L, Allia E, Bisanzi S, Rizzolo R, Gustinucci D, Del Mistro A, Frayle H, Confortini M, Viti J, Iossa A, Cesarini E, Bulletti S, Passamonti B, Gori S, Toniolo L, Bonvicini L, Venturelli F, Wentzensen N, Giorgi Rossi P, NTCC2 Working Group.
    EBioMedicine; 2024 Jun 01; 104():105149. PubMed ID: 38759278
    [Abstract] [Full Text] [Related]

  • 16. Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA.
    Stoler MH, Baker E, Boyle S, Aslam S, Ridder R, Huh WK, Wright TC.
    Int J Cancer; 2020 May 01; 146(9):2599-2607. PubMed ID: 31490545
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China.
    Zhang SK, Jia MM, Zhao DM, Wu ZN, Guo Z, Liu YL, Guo PP, Chen Q, Cao XQ, Liu SZ, Chen W, Sun XB.
    Cancer Epidemiol; 2019 Apr 01; 59():123-128. PubMed ID: 30739069
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.
    Ebisch RM, van der Horst J, Hermsen M, Rijstenberg LL, Vedder JE, Bulten J, Bosgraaf RP, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Massuger LF, Melchers WJ, Bekkers RL, Siebers AG.
    Mod Pathol; 2017 Jul 01; 30(7):1021-1031. PubMed ID: 28304400
    [Abstract] [Full Text] [Related]

  • 19. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
    Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M.
    Clin Cancer Res; 2012 Aug 01; 18(15):4154-62. PubMed ID: 22675168
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.